$7.83
-16%Ardent Health Partners, LLC owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, LLC is a subsidiary of EGI-AM Investments, L.L.C.
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Acceptable margins but limited operational leverage. Operating expense control is important.
Minimal profitability after all expenses. Limited financial flexibility for reinvestment or shareholder returns.
Moderate tax rate typical for most corporations. Represents standard tax burden on profits.
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
ARDT • NYSE
| Ardent Health Partners, LLC Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|
REVENUE | |||||||||
6.3B | 6B | 5.4B | 5.1B | 4.9B | 4.2B | 3B | 2.1B | 2B | |
GROSS PROFIT | |||||||||
(155.7M) | (1B) | (140.8M) | (955.2M) | (927.3M) | (0.0) | (0.0) | (0.0) | (0.0) | |
6.2B | 4.9B | 5.3B | 4.2B | 3.9B | 4.2B | 3B | 2.1B | 2B | |
OPERATING INCOME | |||||||||
(5.8B) | (4.5B) | (5B) | (4B) | (3.5B) | (4.1B) | (2.8B) | (2.1B) | (1.8B) | |
(1.2B) | (3.9B) | (3.6B) | (3.4B) | (3.1B) | (2.7B) | (1.2B) | (1.9B) | (1.8B) | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (15.7M) | (19.9M) | (0.0) | (0.0) | |
325.6M | 405.8M | 229.5M | 217M | 436.6M | 149.8M | 121.8M | 84.8M | 126M | |
PRE-TAX INCOME | |||||||||
(55.2M) | (65.6M) | (65.4M) | (82.1M) | (93.8M) | (108.6M) | (70.7M) | (26.9M) | (64M) | |
-55.2M | -65.6M | -65.4M | -82.1M | -93.8M | -108.6M | -70.7M | -26.9M | 0.0 | |
(4.7B) | (642.5M) | (1.4B) | (585.8M) | (374.2M) | (0.0) | (0.0) | (0.0) | (0.0) | |
-39.2M | -42.7M | -77.9M | 94.5M | -140.7M | -264.4M | -71.1M | -40.4M | -81.2M | |
286.4M | 363.1M | 151.6M | 311.5M | 295.9M | -114.6M | 50.6M | 44.4M | 44.8M | |
NET INCOME | |||||||||
(56.2M) | (63.4M) | (22.6M) | (46.1M) | (51.3M) | -11.3M | (49.9M) | (8M) | (63.9M) | |
135.8M | 210.3M | 50.3M | 188.9M | 154.3M | -143M | -35.6M | 14.6M | -46.4M |
ARDT - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | June 02, 2026 | June 02, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 26, 2026 | May 20, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 06, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 05, 2026 | May 05, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 08, 2026 | May 20, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 27, 2026 | March 24, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 16, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 04, 2026 | March 04, 2026 | 2026 | |
8-K 8-K 2025 N/A | November 18, 2025 | November 17, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 14, 2025 | September 30, 2025 | 2025 |
Continue your ARDT research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.